According to the US Food and Drug Administration (FDA), Bristol-Myers Squibb
Co has initiated a voluntary recall of their blood thinner, Coumadin.
The pharmaceutical company decided to recall six lots of the injectable
version of this blood thinner after finding particulate matter in some
Bristol-Myers called the recall a “precautionary measure” and
claimed there have been no
drug injuries reported in association with this drug. The recall was initiated after
investigators detected some contaminated 5 mg single-use vials.
No Coumadin tablets were included in the recall, which only coves lots
of the injectable form distributed in the United States between November
2011 and January 2014.
If you have suffered an injury from taking one of the recalled lots of
Coumadin, you may be entitled to recover compensation for your damages. The
pharmaceutical injury attorneys at Golomb & Honik have decades of trial experience and have handled
numerous drug injury cases. We have the skills to battle the high-powered
legal teams employed by pharmaceutical companies. This will give you the
edge you need when seeking to maximize the value of your compensation.
contact Golomb & Honik today to schedule your
free drug injury consultation. We serve clients nationwide from our offices in Philadelphia, Pennsylvania.